Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator ( TPA ), and drainage of liquefied clot has become an alternative. 因而,应用不同的酶如尿激酶或组织纤维蛋白溶酶原激活剂来溶解血肿和引流液化的血凝块,成为可供选择的治疗方法。
Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction; 目的探讨静脉溶栓对男女急性心肌梗塞患者的疗效对比。
Comparison of Recombinant Tissue Plasminogen Activator(TPA), Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test 重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
The Initial Research about the Effect of Tissue Plasminogen Activator(TPA) on Neural Repair 组织纤溶酶原激活物对神经修复影响的初步探讨
Expressions of Survivin and uPA in human cerebral gliomas Comparison of Recombinant Tissue Plasminogen Activator(TPA), Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test 脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较